Tag Archives: U.S.

VACUUMSCHMELZE (VAC) and General Motors (GM) Announce Plans to Build a New Magnet Factory in the U.S. to Support EV Growth

Hanau – VAC and GM announced plans for VAC to build a plant in the U.S. that will manufacture permanent magnets for the electric motors used in GM’s electric vehicles using Ultium-Platform. The new plant would plan to use locally sourced raw materials. “We are building a resilient and sustainable EV manufacturing value chain in… Read More »

U.S. FDA Approves ALK’s Ragwitek (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use as Immunotherapy for Children and Adolescents With Short Ragweed Pollen-Induced Allergic Rhinitis With or Without Conjunctivitis

ROUND ROCK, Texas, April 19, 2021 /PRNewswire/ — ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF), a global, research-driven pharmaceutical company that focuses on the diagnosis and treatment of allergies, announced that the U.S. Food and Drug Administration (FDA) approved Ragwitek (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use for the… Read More »

Fast, Less Accurate Coronavirus Tests May Ease the U.S. Backlog, Experts Say

For months, the call for coronavirus testing has been led by one resounding refrain: To keep outbreaks under control, doctors and researchers need to deploy the most accurate tests available — ones reliable enough to root out as many infections as possible, even in the absence of symptoms. That’s long been the dogma of infectious… Read More »